Compare Ginkgo Bioworks Holdings Inc (DNA) vs HubSpot Inc (HUBS) Price & Performance

Ginkgo Bioworks (DNA) trades at $12.84, up 11.94% in the last session. The stock shows a bullish technical signal with strong moving average support, though oscillators are neutral. Fundamentally, the company reported a net loss of $312.76 million in 2025 on $170.16 million revenue, with a negative net margin of 219.6%. Recent news includes a $17.5 million ARPA-H subcontract for RNA medicine manufacturing, highlighting strategic growth initiatives despite financial challenges.

Outlook remains speculative with high risk. The buy/hold/sell analyst split is nearly even, reflecting uncertainty. Significant cash burn and persistent losses pose substantial risks, but partnerships and government contracts offer potential catalysts. Investors should weigh the company's long-term biotechnology prospects against its current lack of profitability and negative cash flow.

HubSpot (HUBS) trades at $233.94, up 6.19% today, with a bearish technical signal but strong recent earnings beats. The company reported Q2 2026 EPS of $3.26, beating estimates of $3.02, continuing a trend of positive surprises. Revenue growth is robust, with 2025 revenue at $3.13 billion, and net income turning positive at $45.91 million. Analyst sentiment remains largely positive with a consensus price target of $243.65, though valuation multiples like a P/E of 82.51 are elevated. Recent news highlights AI strategy advancements and partnerships, including a deepened collaboration with OpenAI.

The outlook for HUBS is cautiously optimistic, driven by strong revenue growth, margin expansion potential, and strategic AI initiatives. Key risks include high valuation multiples, competitive pressures in the CRM space, and potential demand headwinds from economic conditions. Institutional ownership trends show significant interest, such as the California State Teachers Retirement System increasing its stake. The stock presents a growth opportunity but requires monitoring of execution risks and market sentiment shifts.